Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;64(9):833-847.
doi: 10.1038/s10038-019-0614-4. Epub 2019 May 20.

Urea cycle disorders-update

Shirou Matsumoto  1 , Johannes Häberle  2 , Jun Kido  3 , Hiroshi Mitsubuchi  3 , Fumio Endo  4 , Kimitoshi Nakamura  3
Affiliations
Review

Urea cycle disorders-update

Shirou Matsumoto et al. J Hum Genet. 2019 Sep.

Abstract

The urea cycle is a metabolic pathway for the disposal of excess nitrogen, which arises primarily as ammonia. Nitrogen is essential for growth and life-maintenance, but excessive ammonia leads to life-threatening conditions. The urea cycle disorders (UCDs) comprise diseases presenting with hyperammonemia that arise in either the neonatal period (about 50% of cases) or later. Congenital defects of the enzymes or transporters of the urea cycle cause the disease. This cycle utilizes five enzymes, two of which, carbamoylphosphate synthetase 1 and ornithine transcarbamylase are present in the mitochondrial matrix, whereas the others (argininosuccinate synthetase, argininosuccinate lyase and arginase 1) are present in the cytoplasm. In addition, N-acetylglutamate synthase and at least two transporter proteins are essential to urea cycle function. Severity and age of onset depend on residual enzyme or transporter function and are related to the respective gene mutations. The strategy for therapy is to prevent the irreversible toxicity of high-ammonia exposure to the brain. The pathogenesis and natural course are poorly understood because of the rarity of the disease, so an international registry system and novel clinical trials are much needed. We review here the current concepts of the pathogenesis, diagnostics, including genetics and treatment of UCDs.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hum Gene Ther. 2002 Jan 1;13(1):163-75 - PubMed
    1. J Neurosci Res. 2001 Dec 1;66(5):899-908 - PubMed
    1. Eur J Pediatr. 2008 Mar;167(3):305-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3981-6 - PubMed
    1. Int J Vitam Nutr Res. 2011 Mar;81(2-3):101-7 - PubMed

MeSH terms

Substances

LinkOut - more resources